Withdrawal of cerivastatin from the world market

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins et al. · New England Journal of Medicine · 1999 · 3.5K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease

Circulation · 2000 · 1.3K citations

Medicine, Cardiology, Pharmacology +17

Debate: The slippery slope of surrogate outcomes

Ralph B. D’Agostino · Trials · 2000 · 45 citations · Full text

Health Professions, Health Policy, Medical Ethics +10

Bayer faces potential fine over cholesterol lowering drug

A. Tuffs · BMJ · 2001 · 13 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13